STTK
NASDAQ · Biotechnology
Shattuck Labs Inc
$6.73
-0.11 (-1.61%)
Financial Highlights (FY 2026)
Revenue
1.60M
Net Income
-77,874,962
Gross Margin
—
Profit Margin
-4,880.9%
Rev Growth
+15.4%
D/E Ratio
—
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | — | — | 47.5% | 47.5% |
| Operating Margin | -5,150.8% | -4,635.7% | 5.1% | 5.8% |
| Profit Margin | -4,880.9% | -4,636.9% | 3.7% | 4.6% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 1.60M | 1.38M | 31.76M | 28.92M |
| Gross Profit | — | — | 15.09M | 13.75M |
| Operating Income | -82,351,041 | -64,202,994 | 1.63M | 1.67M |
| Net Income | -77,874,962 | -60,713,327 | 1.18M | 1.33M |
| Gross Margin | — | — | 47.5% | 47.5% |
| Operating Margin | -5,150.8% | -4,635.7% | 5.1% | 5.8% |
| Profit Margin | -4,880.9% | -4,636.9% | 3.7% | 4.6% |
| Rev Growth | +15.4% | +15.4% | -3.0% | +24.7% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 0 | 0 | 82.62M | 102.31M |
| Total Equity | — | — | 173.07M | 148.25M |
| D/E Ratio | — | — | 0.48 | 0.69 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | -76,298,366 | -62,788,849 | 2.48M | 2.21M |
| Free Cash Flow | — | — | 903.7K | 487.2K |